Category: Personalized Medicine
Global Personalized Medicine
-
Global Organoids and Spheroids Market Size Study & Forecast, by Type (Organoids Type, Spheroids Type), By Method (Extracellular Matrix Scaffold Method, Spinning Bioreactor Method, Hanging Drop Method, Low Adherent Culture Plate Method, Magnetic Levitation Method), By End-User (Biotechnology And Pharmaceutical Industry, Academic And Research Institutes, Hospitals and Diagnostic Centers), and Regional Analysis, 2023-2030
... By End-User (Biotechnology And Pharmaceutical Industry, Academic And Research Institutes, Hospitals and Diagnostic Centers), and Regional Analysis, 2023-2030 Global Organoids and Spheroids Market is valued at approximately USD 560.51 million in 2022 and is anticipated ... Read More
-
Next Generation Sequencing Market By PRODUCT (Consumables, Platforms, Services), By APPLICATION (Diagnostics, Biomarkers and Cancer, Reproductive Health, Personalized medicine, Agriculture and animal research, Others), By TECHNOLOGY (Sequencing By synthesis (SBS), Ion semiconductor sequencing (IOS), Sequencing By Ligation (SBL), Pyrosequencing, Single-molecule-real-time sequencing (SMRT), Others), By END USER (Academic and clinical research centers, Pharmaceutical and biotechnology companies, Hospitals and clinics, Others): Global Opportunity Analysis and Industry Forecast, 2024-2035
... By Ligation (SBL), Pyrosequencing, Single-molecule-real-time sequencing (SMRT), Others), By END USER (Academic and clinical research centers, Pharmaceutical and biotechnology companies, Hospitals and clinics, Others): Global Opportunity Analysis and Industry Forecast, 2024-2035 The next generation sequencing ... Read More
-
Global Nanomaterials in Personalized Medicine Market Size study & Forecast, by Product Type (Proteins, Monoclonal Antibodies, Nanocrystals, Liposomes, Gold Nanoparticles, Quantum Dots) and Regional Analysis, 2023-2030
... USD 311.50 billion in 2022 and is anticipated to grow with a growth rate of more than 11.3% over the forecast period 2023-2030. Nanomaterials in Personalized Medicine refer to materials at the nanoscale that are ... Read More
-
Imaging Biomarkers Market Size, Trends, Analysis, and Outlook By Technology (Positron Emission Tomography (PET), Ultrasound, Magnetic Resonance Imaging, Computed Tomography (CT), Single-Photon Emission Computerized Tomography (SPECT), Others), By Application (Personalized Medicine, Drug Discovery and Development, Molecular Diagnostics, Drug Formulation, Disease), By Diagnosis (Forensic Applications, Others), by Region, Country, Segment, and Companies, 2024-2030
... Molecular Diagnostics, Drug Formulation, Disease), By Diagnosis (Forensic Applications, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Imaging Biomarkers market size is poised to register 13.91% growth (CAGR) from 2024 to 2030, presenting ... Read More
-
Global Artificial Intelligence (Ai) In Healthcare Market Forecast 2024-2032
... elevate the market growth: large volumes of healthcare data supporting the adoption of AI, investments towards AI research & development coupled with proactive government support, a growing number of AI and machine learning start-ups, the ... Read More
-
Next-Generation Sequencing Market Assessment, By Product [NGS Consumables, Presequencing Products and Services, Sequencing Services, NGS Platforms, Bioinformatics, Services for NGS Platforms], By Sequencing Type [RNA Sequencing, Whole Genome Sequencing, Whole Exome Sequencing, Targeted Resequencing, CHIP Sequencing, De Novo Sequencing, Methyl Sequencing, Others], By Technology [Sequencing by Synthesis, Single-Molecule Real-Time Sequencing, Nanopore Sequencing, Ion Semiconductor Sequencing, Others], By Application [Drug Discovery and Personalized Medicine, Diagnostics, Genetic Screening, Agriculture and Animal Research, Others], By End-user [Hospitals and Clinics, Academic Institutes and Research Centers, Pharmaceutical and Biotechnology Companies, Others], By Region, Opportunities and Forecast, 2017-2031F
... Sequencing, De Novo Sequencing, Methyl Sequencing, Others], By Technology [Sequencing by Synthesis, Single-Molecule Real-Time Sequencing, Nanopore Sequencing, Ion Semiconductor Sequencing, Others], By Application [Drug Discovery and Personalized Medicine, Diagnostics, Genetic Screening, Agriculture and Animal Research, ... Read More
-
Tumor Profiling Market Size, Trends, Analysis, and Outlook By Cancer (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, Others), By Biomarker, Genomic Biomarker, Protein Biomarker), By Technology (Immunoassays, Next-Generation Sequencing, Polymerase Chain Reaction, Mass Spectrometry, In-Situ Hybridization, Microarrays, Others), By Technique (Genomics, Proteomics, Metabolomics, Epigenetics), By Application (Research, Biomarker Discovery, Personalized Medicine, Clinical Application, Diagnostics, Prognostics, Screening, Treatment and Monitoring), by Region, Country, Segment, and Companies, 2024-2030
... Mass Spectrometry, In-Situ Hybridization, Microarrays, Others), By Technique (Genomics, Proteomics, Metabolomics, Epigenetics), By Application (Research, Biomarker Discovery, Personalized Medicine, Clinical Application, Diagnostics, Prognostics, Screening, Treatment and Monitoring), by Region, Country, Segment, and Companies, 2024-2030 The ... Read More
-
Organoids and Spheroids Market Size, Trends, Analysis, and Outlook Organoids By Type (Neural Organoids, Hepatic Organoids, Intestinal Organoids, Others), Organoids By Method (General Submerged Method for Organoid Culture, Crypt Organoid Culture Techniques, Air Liquid Interface (ALI) Method for Organoid Culture, Clonal Organoids from Lgr5+ Cells, Brain and Retina Organoid Formation Protocol, Organoids By Source (Primary Tissues, Stem Cells), Spheroids By Type (Multicellular tumor spheroids (MCTS), Neurospheres, Mammospheres, Hepatospheres, Embryoid bodies), Spheroids By Method (Micropatterned Plates, Low Cell Attachment Plates, Hanging Drop Method, Others), Spheroids By Source (Cell Line, Primary Cell, iPSCs Derived Cells), By Application (Developmental Biology, Personalized Medicine, Regenerative Medicine, Disease Pathology Studies, Drug Toxicity & Efficacy Testing), By End-user (Biotechnology and pharmaceutical industries, Academic & Research Institutes, Hospitals and diagnostic cente
... (ALI) Method for Organoid Culture, Clonal Organoids from Lgr5+ Cells, Brain and Retina Organoid Formation Protocol, Organoids By Source (Primary Tissues, Stem Cells), Spheroids By Type (Multicellular tumor spheroids (MCTS), Neurospheres, Mammospheres, Hepatospheres, Embryoid bodies), ... Read More
-
The 2025-2030 World Outlook for Cellular Health Screenings
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Personalized Retail Nutrition and Wellness
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Predictive Healthcare Analytics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Cellular Health Screening-Health Testing
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Personalized Medicine and Epigenomics
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Precision Medicine (Diagnostics-Therapeutics)
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Precision Medicines
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Tests and Lab Services for Personalized Medicines
... estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. ... Read More
-
The 2025-2030 World Outlook for Personalized Medicines
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Precision Medicine Software
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Single-Test Panels for Cellular Health Screening and Health Testing
... For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, ... Read More
-
Personalized Medicine Global Market Report 2024
... End-use: Hospitals; Diagnostic Centers; Research and Academic InstitutesCovering: Bayer AG; Novartis AG; Thermo Fisher Scientific Inc.; GlaxoSmithKline plc; AstraZeneca plc Personalized Medicine Global Market Report 2024 from The Business Research Company provides strategists, marketers and ... Read More
-
Pharmacogenomics Market by Product & Service (Kits & Reagents), Technology (Sequencing, PCR, Microarray), Application (Drug Discovery, Clinical Research, Personalized Medicine), Disease Area (Cancer, Neurological, Cardiovascular) - Global Forecast to 2028
... to reach USD 5.8 billion by 2028 from an estimated USD 3.5 billion in 2023, at a CAGR of 10.6% during the forecast period. The growth of this market can be attributed to the research ... Read More
-
Global Multiomics Market, By Product & Service (Products, Services), By Type (Single-cell Multiomics, Bulk Multiomics), By Platform (Genomics, Transcriptomics, Proteomics, Metabolomics, Integrated Omics Platforms), By Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, AgriGenomics, Others), By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Clinical Research Organizations, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Clinical Research Organizations, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) The global multiomics market was valued at ... Read More
-
Global DNA Sequencing Market Assessment, By Product Type [Consumables, Instruments, Services], By Technology [Sanger Sequencing, Next Generation Sequencing, Other Sequencing Technologies], By Application [Diagnostic Applications, Personalized Medicine, Research Applications], By End-users [Hospitals and Healthcare Organizations, Academics and Research Institutions, Pharmaceutical and Biotechnology Companies, Others], By Region, Opportunities and Forecast, 2017-2031F
... Academics and Research Institutions, Pharmaceutical and Biotechnology Companies, Others], By Region, Opportunities and Forecast, 2017-2031F Global DNA sequencing market size was valued at USD 8.16 billion in 2023, which is expected to reach USD 24.51 ... Read More
-
DNA Sequencing Products Market Report by Product Type (Consumables and Reagents, Equipments), Application (Biomarkers, Diagnostics, Reproductive Health, Forensics, Personalized Medicine, and Others), End-User (Academic and Government Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Others), and Region 2024-2032
... and Others), and Region 2024-2032 The global DNA sequencing products market size reached US$ 6.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 15.5 Billion by 2032, exhibiting a growth ... Read More
-
Generative AI in Personalized Medicine Market Report: Trends, Forecast and Competitive Analysis to 2030
... with opportunities in the hospital and clinic, clinical research, healthcare organization, and diagnostic center markets. Generative AI in the global personalized medicine market is expected to grow with a CAGR of 39.5% from 2024 to ... Read More
Research Assistance
